NeuroCAN Identifying and disrupting neuroimmune circuits in cancer
- Coordinator
- Universitat Basel, Switzerland
- Runs
- 1 July 2027 to 30 June 2032
- Status
- Running
- EU funding
- €1.9m
- Total cost
- €1.9m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101300481
What the project is doing
In the project's own words, from its summary on CORDIS.
Emerging evidence reveals that the peripheral nervous system plays an active role in cancer progression and immune regulation. Yet how sensory neurons detect inflammatory cues within tumors and influence systemic immunity remains poorly understood. This project aims to uncover the mechanisms by which cytokine-sensing vagal afferents and neuropeptide signaling shape anti-tumor immune responses in lung cancer. Our preliminary data indicate that local neural circuits in the lung shape immune cell behavior and response via bidirectional signaling with the immune system.
We hypothesize that this circuitry becomes dysregulated in cancer to promote immune evasion. We propose to integrate neuroanatomical tracing, single-cell transcriptomics, cell-specific knockout models, and functional circuit manipulation to define how lung-innervating sensory neurons are remodeled by tumors and, in turn, regulate immune cell recruitment, activation, and effector function within the tumor microenvironment.
Functional studies combining cytokine stimulation, chemogenetic perturbation, and cytokine-TRAP mapping will establish causal links between tumor-derived cytokines and neural activity. In parallel, we will define how neuropeptides such as CGRP modulate dendritic cell function and immune remodeling within the tumor microenvironment, integrating genetic loss-of-function and high-dimensional profiling in syngeneic models of lung cancer.
By connecting neural sensing of inflammation to immune evasion, this interdisciplinary program will uncover a sensory immune axis that governs tumor-host communication, opening new conceptual and therapeutic avenues at the interface of neuroscience, immunology, and cancer biology.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitat Basel | Basel | Switzerland | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS